235/65R17 Continental CrossContact UHP N0 108V XL Tyre

235/65R17 Continental CrossContact UHP N0 108V XL Tyre

Marsoni

M251S

$1492.50

Get it in 3 business days with 1 day shipping. Friday, May 29

235/65R17 Continental CrossContact UHP N0 108V XL TyreThe Continental CrossContact UHP is an ultra high performance Tyre designed for powerful SUVs and sporty crossovers, providing outstanding handling, grip, and safety at high speeds. Its asymmetric tread pattern with rigid shoulder blocks ensures precise steering response and stability during cornering, making it ideal for dynamic driving. The advanced silica compound enhances traction and reduces braking distances on both wet and dry roads, while the

Easy Shipping

Quick Dispatch:

Your 235/65R17 Continental CrossContact UHP N0 108V XL Tyre orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your 235/65R17 Continental CrossContact UHP N0 108V XL Tyre ships.

Need Help?
Questions about 235/65R17 Continental CrossContact UHP N0 108V XL Tyre, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for 235/65R17 Continental CrossContact UHP N0 108V XL Tyre in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

If I could give this zero stars, I absolutely would. I ordered these shoes expecting them to be brand new since I paid full price and never selected any “used” option. What I received instead were clearly heavily worn shoes there were visible signs of use that you simply wouldn’t expect from a new product.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on March 25, 2026